Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06684080Not ApplicableNot Yet Recruiting

The Effectiveness of a Care Bundle to Prevent Postpartum Hemorrhage After Cesarean Delivery

Role: lead

NCT05433870Completed

Inflammatory Biomarkers for the Diagnosis of oPRES

Role: lead

NCT05310513Completed

The Predictors of ICU Admission of oPRES

Role: lead

NCT05143710Completed

The Clinical and Prognostic Features of PRES

Role: lead

NCT05134285Unknown

Effects of Recurrent PE on Women and Offspring

Role: lead

NCT05140850Unknown

Long-term Consequences of Neuroimaging and Perceived Cognitive Dysfunction in oPRES

Role: lead

All 6 trials loaded